fbpx

Chantix Stop-Smoking Drug Adulterated with Nitrosamines Complaint

November 7, 2022

Pfizer, Inc. makes the varenicline-containing drug (VCD) Chantix, which is used to help smokers stop smoking. The complaint for this class action alleges that Chantix has recently been adulterated or misbranded because it has been contaminated with a probable carcinogen called N-nitroso-varenicline.

Case Event File: Chantix Stop-Smoking Drug Adulterated with Nitrosamines Complaint

Related to: Chantix Stop-Smoking Drug Adulterated with Nitrosamines Class Action